Cell and Gene Therapy

The latest market intelligence, insights and interviews covering the cell and gene therapy industry's most pressing challenges, from translation to automation, manufacturing to market access, viral vectors to bioreactors.

 

Cell and Gene Therapy
25/06/2019

Edition one of Phacilitate’s technology review series examines gene editing approaches by viral and non-viral methods and where...

Cell and Gene Therapy
28/05/2019

Episode two of the Phacilitate Leaders World super plenary sessions with Dave Lennon, President of AveXis, Inc